Caplyta (Lumateperone)

Lumateperone is a medicine used to treat schizophrenia, bipolar depression, and depression when an antidepressant alone isn't enough. It's taken as a capsule once a day. It works by changing the balance of brain chemicals like serotonin and dopamine.

Brand names:Caplyta
Medication

What people taking Caplyta (Lumateperone) report

Every report comes from a Lived member, sent anonymously.

Have you tried Caplyta (Lumateperone) for Bipolar Disorder?

NameHow it went

About Caplyta (Lumateperone)

What It's For

Lumateperone, sold in the US as Caplyta, is a prescription atypical antipsychotic taken by mouth. In adults it is approved for three uses: treating schizophrenia; treating depressive episodes of bipolar I or bipolar II disorder (bipolar depression), either on its own or added to lithium or valproate; and as an add-on to an antidepressant for major depressive disorder when the antidepressant alone has not been enough. The word antipsychotic reflects its original use in schizophrenia, a condition that affects how a person thinks and perceives reality. In bipolar depression and major depression it is used for its effect on mood, not because the person has psychosis. It is not approved for children or teenagers, and it is not approved for treating psychosis or agitation linked to dementia.

How It Works

Serotonin and dopamine are chemical messengers that help regulate mood, motivation, perception and movement. Lumateperone blocks one type of serotonin receptor (5-HT2A) and partly stimulates, rather than fully blocks, one type of dopamine receptor (D2). Taken together, these actions are thought to steady signaling in brain circuits involved in psychosis and depression while interfering less with dopamine than many older antipsychotics do. The US Food and Drug Administration (FDA) label states that the exact reason it helps is not known. The receptor effects describe what the drug does in the brain, not a complete explanation of why a particular person improves.

Dosage & Administration

Lumateperone comes as capsules taken once a day, with or without food. Unlike many antipsychotics, it is usually started at the full standard dose of 42 mg rather than being increased gradually, and the same dose is used for all three approved conditions. Lower-strength capsules (21 mg and 10.5 mg) exist for people whose bodies clear the drug more slowly: those with moderate or severe liver disease, and those taking certain other medicines that raise lumateperone levels (described under Interactions & Warnings). Because a new prescription can change the right dose, tell the prescriber or pharmacist whenever another medicine is started or stopped.

Side Effects

Sleepiness or sedation is the side effect people notice most, along with dizziness, dry mouth and nausea. Headache, fatigue and diarrhea were also more common than with placebo in the depression studies. These effects are usually most noticeable in the first weeks. Some people feel lightheaded when standing up quickly, which matters most for older adults and anyone taking blood pressure medicines, because it can lead to falls. Like other antipsychotics, lumateperone can cause movement side effects. Tardive dyskinesia is repetitive, involuntary movement, often of the lips, tongue, face or fingers; it can develop over time, sometimes persists after the medicine is stopped, and should be reported early. In the first few days, a few people develop sudden muscle spasms of the neck or jaw; spasm that tightens the throat or makes breathing or swallowing hard needs emergency care. Neuroleptic malignant syndrome is a rare but life-threatening reaction: high fever with stiff muscles, confusion, sweating or a racing heart needs emergency care right away. In clinical trials, weight, blood sugar and cholesterol changed about as much with lumateperone as with placebo. Antipsychotics as a group can raise all three, though, so prescribers still check them.

Interactions & Warnings

Lumateperone has two boxed warnings, the FDA's most prominent kind. First, older adults with dementia who are given antipsychotics for psychosis have a higher risk of death, including from stroke, so lumateperone is not used for that purpose. Second, medicines that treat depression have been linked to more suicidal thoughts and behaviors in children, teenagers and young adults. Anyone taking it, and the people close to them, should watch for worsening depression, new suicidal thoughts or unusual changes in behavior, especially in the first months and after a dose change, and contact the prescriber promptly if they appear. The liver breaks down lumateperone using an enzyme called CYP3A4 (a member of the liver's cytochrome family of drug-processing enzymes). Medicines that block this enzyme, such as the antifungals itraconazole and fluconazole and the antibiotics clarithromycin and erythromycin, can raise lumateperone levels and call for a lower dose. Medicines that speed the enzyme up, such as the seizure medicines carbamazepine and phenytoin and the tuberculosis antibiotic rifampin, can make lumateperone ineffective and should be avoided with it. Because it also acts on serotonin, combining it with a selective serotonin reuptake inhibitor (SSRI) or serotonin-norepinephrine reuptake inhibitor (SNRI) antidepressant (the usual setup for depression) calls for some extra watchfulness for serotonin-related problems such as serotonin syndrome or low blood sodium. Sleepiness can slow reactions, so avoid driving or operating machinery until you know how it affects you; alcohol and other sedating medicines add to this effect. The body may handle heat less well, so take care with hard exercise and hot weather and drink enough fluids. People with a history of seizures, low white blood cell counts or heart disease should make sure the prescriber knows. Taking an antipsychotic late in pregnancy can cause temporary breathing, feeding or movement problems in the newborn, so anyone pregnant or planning pregnancy should talk with the prescriber, since stopping treatment suddenly carries its own risks.

What to Expect

In the studies that led to approval, people with schizophrenia were measured after four weeks and people with depression after six weeks, so benefit is generally judged over weeks rather than days. Sleepiness and dizziness often appear before any improvement in mood or symptoms. If there is little change after a fair trial, or the side effects are hard to live with, the prescriber may adjust other parts of the treatment or switch to a different medicine. Before or soon after starting, and from time to time afterward, the prescriber will usually check weight, blood sugar and cholesterol, and will ask about mood and any unusual movements. Schizophrenia and bipolar disorder are long-term conditions, so many people continue treatment after symptoms improve to lower the chance of relapse. Decisions about stopping or switching are best made with the prescriber rather than alone.

Questions to Ask Your Doctor

  1. 1.Why is lumateperone a good fit for me compared with other antipsychotics or add-on options?
  2. 2.Do any of my current medicines or supplements change the dose I need?
  3. 3.How will we judge whether it is working, and after how many weeks?
  4. 4.Which tests will I need while I take it, and how often?
  5. 5.If I want to become pregnant or stop the medicine, what should the plan be?

Last reviewed • Oct 2026

Educational content, not medical advice.